ResearcherLiaocheng People's HospitalNo recent work listed

Yuhong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2358-5449; OpenAlex author ID A5100341160. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. Co-author DOI 10.1016/j.lfs.2020.117936 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jing Ye · 1 shared paper, 2020 · strength 0.11
- Paper The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. DOI 10.1016/j.lfs.2020.117936 ↗
Mu Li · 1 shared paper, 2020 · strength 0.11
- Paper The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. DOI 10.1016/j.lfs.2020.117936 ↗
Yang Ge · 1 shared paper, 2020 · strength 0.11
- Paper The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. DOI 10.1016/j.lfs.2020.117936 ↗
Shaowei Song · 1 shared paper, 2020 · strength 0.11
- Paper The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. DOI 10.1016/j.lfs.2020.117936 ↗
Xiaodong Tan · 1 shared paper, 2020 · strength 0.11
- Paper The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. DOI 10.1016/j.lfs.2020.117936 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.